Under the auspices of the CAS Beijing Genomics Institute and the Ministry of Finance, CAS representatives from Guangzhou, Wuhan, Shanghai, Kunming and Beijing have agreed to form an alliance for upgrading and sharing genome sequencing technology within the 135 program. This step will also include various hospitals under the CAS.

China Bio news release, Feb. 16, 2015